Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Oct;20(4):503–507. doi: 10.1128/aac.20.4.503

Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.

S E Sicher, J O Oh
PMCID: PMC181732  PMID: 6282195

Abstract

New Zealand white rabbits less than 30 h old were inoculated subcutaneously with 10(3) 50% tissue culture infectious doses of type 2 herpes simplex virus. The animals were randomly assigned to a treatment schedule of daily intraperitoneal injections of acyclovir, beginning on the day of virus inoculation for 6 or 12 days, on post-inoculation day 1 for 6 days, or on post-inoculation day 2 for 6 days. The acyclovir was given in doses of 50 mg/kg of body weight per day. Similarly infected animals receiving daily intraperitoneal injection of Eagle minimum essential medium served as controls. All of the control animals died on day 4 or 5 after inoculation. At death they exhibited severe skin lesions, viremia, and dissemination of virus in various visceral organs and spinal as well as trigeminal ganglia. In contrast, animals treated with acyclovir failed to develop significant skin lesions, and death did not occur while treatment continued. Termination of treatment after 6 days resulted in late-onset fatal disease and virus isolation from the brain in many rabbits regardless of the treatment schedule. No such late fatality was observed and no virus could be detected from the brain when treatment was initiated on the day of virus inoculation and continued for 12 consecutive days. With respect to all of the variables studied, treatment for 12 days beginning on the day of virus inoculation was most effective.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYUM A. SEPARATION OF WHITE BLOOD CELLS. Nature. 1964 Nov 21;204:793–794. doi: 10.1038/204793a0. [DOI] [PubMed] [Google Scholar]
  2. Bauer D. J., Collins P., Tucker W. E., Jr, Macklin A. W. Treatment of experimental herpes simplex keratitis with acycloguanosine. Br J Ophthalmol. 1979 Jun;63(6):429–435. doi: 10.1136/bjo.63.6.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boulter E. A., Thornton B., Bauer D. J., Bye A. Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir. Br Med J. 1980 Mar 8;280(6215):681–683. doi: 10.1136/bmj.280.6215.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ch'ien L. T., Whitley R. J., Nahmias A. J., Lewin E. B., Linnemann C. C., Jr, Frenkel L. D., Bellanti J. A., Buchanan R. A., Alford D. A., Jr Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May;55(5):678–685. [PubMed] [Google Scholar]
  5. Charnock E. L., Cramblett H. G. 5-iodo-2'-deoxyuridine in neonatal herpesvirus hominis encephalitis. J Pediatr. 1970 Mar;76(3):459–463. doi: 10.1016/s0022-3476(70)80491-7. [DOI] [PubMed] [Google Scholar]
  6. Chow A. W., Roland A., Fiala M., Hryniuk W., Weil M. L., Geme J. S., Jr, Guze L. B. Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother. 1973 Mar;3(3):412–417. doi: 10.1128/aac.3.3.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colby B. M., Shaw J. E., Elion G. B., Pagano J. S. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol. 1980 May;34(2):560–568. doi: 10.1128/jvi.34.2.560-568.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crumpacker C. S., Schnipper L. E., Zaia J. A., Levin M. J. Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979 May;15(5):642–645. doi: 10.1128/aac.15.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Falcon M. G., Jones B. R. Acycloguanosine: antiviral activity in the rabbit cornea. Br J Ophthalmol. 1979 Jun;63(6):422–424. doi: 10.1136/bjo.63.6.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Field H. J., Bell S. E., Elion G. B., Nash A. A., Wildy P. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother. 1979 Apr;15(4):554–561. doi: 10.1128/aac.15.4.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Field H. J., Darby G., Wildy P. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol. 1980 Jul;49(1):115–124. doi: 10.1099/0022-1317-49-1-115. [DOI] [PubMed] [Google Scholar]
  13. Field H. J., Hill T. J. The pathogenesis of pseudorabies in mice: virus replication at the inoculation site and axonal uptake. J Gen Virol. 1975 Jan;26(1):145–148. doi: 10.1099/0022-1317-26-1-145. [DOI] [PubMed] [Google Scholar]
  14. Golden B., Bell W. E., McKee A. P. Disseminated herpes simplex with encephalitis in a neonate. Treatment with idoxuridine. JAMA. 1969 Aug 25;209(8):1219–1221. [PubMed] [Google Scholar]
  15. Hanshaw J. B. Herpesvirus hominis infections in the fetus and the newborn. Am J Dis Child. 1973 Oct;126(4):546–555. doi: 10.1001/archpedi.1973.02110190442018. [DOI] [PubMed] [Google Scholar]
  16. Jones B. R., Coster D. J., Fison P. N., Thompson G. M., Cobo L. M., Falcon M. G. Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet. 1979 Feb 3;1(8110):243–244. doi: 10.1016/s0140-6736(79)90769-4. [DOI] [PubMed] [Google Scholar]
  17. Kaufman H. E., Varnell E. D., Centifanto Y. M., Rheinstrom S. D. Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits. Antimicrob Agents Chemother. 1978 Dec;14(6):842–845. doi: 10.1128/aac.14.6.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nahmias A. J., Alford C. A., Korones S. B. Infection of the newborn with herpesvirus hominis. Adv Pediatr. 1970;17:185–226. [PubMed] [Google Scholar]
  19. Oh J. O., Minasi P. Different susceptibilities of skin to type 1 and type 2 herpes simplex viruses in newborn rabbits. Infect Immun. 1980 Jan;27(1):168–174. doi: 10.1128/iai.27.1.168-174.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Park N. H., Pavan-Langston D., McLean S. L. Acylovir in oral and ganglionic herpes simplex virus infections. J Infect Dis. 1979 Nov;140(5):802–806. doi: 10.1093/infdis/140.5.802. [DOI] [PubMed] [Google Scholar]
  21. Park N. H., Pavan-Langston D., McLean S. L., Albert D. M. Therapy of experimental herpes simplex encephalitis with aciclovir in mice. Antimicrob Agents Chemother. 1979 Jun;15(6):775–779. doi: 10.1128/aac.15.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Partridge J. W., Millis R. R. Systemic herpes simplex infection in a newborn treated with intravenous idoxuridine. Arch Dis Child. 1968 Jun;43(229):377–381. doi: 10.1136/adc.43.229.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pavan-Langston D., Campbell R., Lass J. Acyclic antimetabolite therapy of experimental herpes simplex keratitis. Am J Ophthalmol. 1978 Nov;86(5):618–623. doi: 10.1016/0002-9394(78)90178-2. [DOI] [PubMed] [Google Scholar]
  24. Pavan-Langston D., Park N. H., Lass J. H. Herpetic ganglionic latency. Aciclovir and vidarabine therapy. Arch Ophthalmol. 1979 Aug;97(8):1508–1510. doi: 10.1001/archopht.1979.01020020170017. [DOI] [PubMed] [Google Scholar]
  25. Pettay O., Leinikki P., Donner M., Lapinleimu K. Herpes simplex virus infection in the newborn. Arch Dis Child. 1972 Feb;47(251):97–103. doi: 10.1136/adc.47.251.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Roberts J. K. A case of genital herpesvirus infection in pregnancy. J Obstet Gynaecol Br Commonw. 1973 Feb;80(2):188–190. doi: 10.1111/j.1471-0528.1973.tb02180.x. [DOI] [PubMed] [Google Scholar]
  27. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  28. Selby P. J., Powles R. L., Janeson B., Kay H. E., Watson J. G., Thornton R., Morgenstern G., Clink H. M., McElwain T. J., Prentice H. G. Parenteral acyclovir therapy for herpesvirus infections in man. Lancet. 1979 Dec 15;2(8155):1267–1270. doi: 10.1016/s0140-6736(79)92281-5. [DOI] [PubMed] [Google Scholar]
  29. Shiota H., Inoue S., Yamane S. Efficacy of acycloguanosine against herpetic ulcers in rabbit cornea. Br J Ophthalmol. 1979 Jun;63(6):425–428. doi: 10.1136/bjo.63.6.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tuffi G. A., Nahmias A. J. Neonatal herpetic infection. Report of two premature infants treated with systemic use of idoxuridine. Am J Dis Child. 1969 Dec;118(6):909–914. [PubMed] [Google Scholar]
  31. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  32. de Miranda P., Whitley R. J., Blum M. R., Keeney R. E., Barton N., Cocchetto D. M., Good S., Hemstreet G. P., 3rd, Kirk L. E., Page D. A. Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther. 1979 Dec;26(6):718–728. doi: 10.1002/cpt1979266718. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES